Ousaka Daiki, Fujii Yasuhiro, Oozawa Susumu, Nishibori Masahiro, Kuroko Yosuke, Masuda Zenichi, Sano Shunji
Department of Cardiovascular Surgery, Okayama University School of Medicine, Dentistry Pharmaceutical Science, Okayama, Japan.
Department of Cardiovascular Surgery, Okayama University School of Medicine, Dentistry Pharmaceutical Science, Okayama, Japan.
Ann Vasc Surg. 2017 May;41:265-270. doi: 10.1016/j.avsg.2016.08.017. Epub 2016 Nov 28.
High-mobility group box 1 (HMGB-1) is a key substance mediating inflammation and development of atherosclerotic lesions (ALs), including abdominal aortic aneurysms (AAA). Serum levels of HMGB-1 are increased in patients with AAA than those in normal controls because the ALs in AAAs secrete HMGB-1. We therefore postulate that the serum HMGB-1 level should decrease after endovascular aortic repair (EVAR) or open aortic repair (OAR). However, there is no evidence of this in the literature. The purpose of this study was to investigate the changes in HMGB-1 levels after surgical intervention for AAA. We also aimed to determine if the HMGB-1 levels varied between the two procedures.
Serum HMGB-1 levels were determined in 24 patients with AAA and 25 healthy controls. Twelve of the 24 AAA patients underwent EVAR, whereas the other half underwent OAR. The relationship between HMGB-1 levels and presence of AAA or influence of operative methods on the serum HMGB-1 level were prospectively investigated.
Serum HMGB-1 levels in AAA patients were significantly higher than those in healthy controls (9.4 ± 5.7 vs. 4.1 ± 2.0 ng/mL, P < 0.01). The serum HMGB-1 levels in both the EVAR group and the OAR group were significantly decreased from baseline at both 3 mo and 1 y after surgery.
Removal or isolation of AL via surgical intervention significantly decreases serum HMGB-1 levels. The significant postoperative reduction in HMGB-1 levels suggests that important endocrinological changes occur after surgical treatment of AAA.
高迁移率族蛋白B1(HMGB - 1)是介导炎症和动脉粥样硬化病变(包括腹主动脉瘤,AAA)发展的关键物质。AAA患者血清中HMGB - 1水平高于正常对照组,因为AAA中的动脉粥样硬化病变会分泌HMGB - 1。因此,我们推测在血管腔内主动脉修复术(EVAR)或开放性主动脉修复术(OAR)后,血清HMGB - 1水平应会降低。然而,文献中尚无此方面的证据。本研究的目的是调查AAA手术干预后HMGB - 1水平的变化。我们还旨在确定两种手术方法之间HMGB - 1水平是否存在差异。
测定24例AAA患者和25例健康对照者的血清HMGB - 1水平。24例AAA患者中有12例接受了EVAR,另一半接受了OAR。前瞻性研究HMGB - 1水平与AAA存在之间的关系或手术方法对血清HMGB - 1水平的影响。
AAA患者的血清HMGB - 1水平显著高于健康对照者(9.4±5.7 vs. 4.1±2.0 ng/mL,P < 0.01)。EVAR组和OAR组的血清HMGB - 1水平在术后3个月和1年时均较基线显著降低。
通过手术干预切除或隔离动脉粥样硬化病变可显著降低血清HMGB - 1水平。术后HMGB - 1水平的显著降低表明AAA手术治疗后发生了重要的内分泌变化。